Biopharma company Morphotek Inc. says it has signed an evaluation agreement with the University Hospital Heidelberg in Germany for work on developing oncology therapeutic antibodies.
Original post:
Morphotek in research deal with German university (The Philadelphia Inquirer)
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.